A Prospective Study Of Pregnancies Exposed to UCB Antiepileptic Drugs to Determine if There is a Potential Increase in the Risk of Major Birth Defects.
Phase of Trial: Phase IV
Latest Information Update: 15 Sep 2016
At a glance
- Drugs Levetiracetam (Primary) ; Antiepileptic drugs
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors UCB
- 01 Sep 2016 Status changed from active, no longer recruiting to completed.
- 22 Dec 2015 Planned End Date changed from 1 Aug 2016 to 1 Mar 2016 as per ClinicalTrials.gov record.
- 22 Dec 2015 Planned primary completion date changed from 1 Aug 2016 to 1 Mar 2016 as per ClinicalTrials.gov record.